VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.4678
-0.0270 (-5.46%)
May 13, 2025, 4:00 PM - Market closed
VolitionRx Market Cap
VolitionRx has a market cap or net worth of $45.16 million as of May 14, 2025. Its market cap has decreased by -38.13% in one year.
Market Cap
45.16M
Enterprise Value
47.72M
1-Year Change
-38.13%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since March 2, 2012, VolitionRx's market cap has increased from $24.40M to $45.16M, an increase of 85.09%. That is a compound annual growth rate of 4.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 12, 2025 | 47.80M | -14.03% |
Dec 31, 2024 | 55.60M | -1.42% |
Dec 29, 2023 | 56.40M | -59.66% |
Dec 30, 2022 | 139.80M | -16.84% |
Dec 31, 2021 | 168.10M | -10.35% |
Dec 31, 2020 | 187.50M | -3.75% |
Dec 31, 2019 | 194.80M | 204.38% |
Dec 31, 2018 | 64.00M | -17.95% |
Dec 29, 2017 | 78.00M | -34.56% |
Dec 30, 2016 | 119.20M | 43.44% |
Dec 31, 2015 | 83.10M | 47.34% |
Dec 31, 2014 | 56.40M | 102.88% |
Dec 31, 2013 | 27.80M | -0.36% |
Dec 31, 2012 | 27.90M | 14.34% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.08B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |